Answers are grounded in this paper and cite their sources.
Background: Clinical examination alone is still challenging to differentiate ovarian cancer from benign ovarian illness. In this study, we assessed the combined use of tumor markers HE4 and CA-125 with oxidative-stress indicators in an effort to obtain a wider biochemical profile of ovarian illness. Materials and Methods: The case-control study consisted of 105 women, 35 women in each of three groups: healthy controls, benign ovarian tumor patients, and women with stage III, grade 3 ovarian cancer. Serum HE4 and CA-125 were tested by ELISA kits. Total oxidant status (TOS), total antioxidant capacity (TAC) and malondialdehyde (MDA) were measured by colorimetric method and oxidative stress index (OSI) was computed from TOS and TAC. We assessed group comparisons, receiver operating characteristic analysis, correlations and odds ratios. Results: In controls, the level of HE4 was 27.42 ± 5.21 pmol/L, in benign illness 58.64 ± 8.63 pmol/L and in malignancy 183.32 ± 41.93 pmol/L. CA-125 rose from 11.95 ± 1.79 to 80.28 ± 17.54 to 548.83 ± 93.55 U/mL. TOS, MDA and OSI showed a gradual increase but TAC showed a substantial decrease among groups (P<0.001). CA-125 and HE4 had excellent discriminating between malignant and benign illness with AUCs of 1.000 and 0.998, respectively; OSI also performed well (AUC=0.941). Tumor markers were positively connected with oxidant indicators and negatively correlated with TAC. Discussion: The results show a gradual transition from the healthy status to the benign disease and advanced malignancy with increasing values of tumor markers and increased oxidative imbalance. We suggest that integration of tumor related and redox indicators may give supplementary information on ovarian disease severity. These results favor integrated assessment over dependence on a single circulating marker.
No takes yet. Share an insight, caveat, or question.
Zahraa Ali Jaafar (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: